儿童胸部实体肿瘤外科诊疗流程的专家共识

参考文献/References:

[1] Siegel DA, King J, Tai E, et al.Cancer incidence rates and trends among children and adolescents in the United States, 2001-2009[J].Pediatrics, 2014, 134(4):e945-e955.DOI:10.1542/peds.2013-3926.
[2] Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015[J].CA Cancer J Clin, 2016, 66(2):115-132.DOI:10.3322/caac.21338.
[3] Lam CG, Howard SC, Bouffet E, et al.Science and health for all children with cancer[J].Science, 2019, 363(6432):1182-1186.DOI:10.1126/science.aaw4892.
[4] Jarvis H, Cost NG, Saltzman AF.Testicular tumors in the pediatric patient[J].Semin Pediatr Surg, 2021, 30(4):151079.DOI:10.1016/j.sempedsurg.2021.151079.
[5] Verly IR, van Kuilenburg AB, Abeling NG, et al.Catecholamines profiles at diagnosis:Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients[J].Eur J Cancer, 2017, 72:235-243.DOI:10.1016/j.ejca.2016.12.002.
[6] Kang NM, Xiao N, Sun XJ, et al.Analysis of ICU treatment on resection of giant tumors in the mediastinum of the thoracic cavity[J].Asian Pac J Cancer Prev, 2013, 14(6):3843-3846.DOI:10.7314/apjcp.2013.14.6.3843.
[7] Guo N, Yu C, Liu Y, et al.Analysis of 50 cases of operated giant thoracic tumors[J].J BUON, 2015, 20(5):1360-1367.
[8] Liu B, Liu L, Li Y.Giant solitary fibrous tumor of the pleura:A case report[J].Thorac Cancer, 2015, 6(3):368-371.DOI:10.1016/j.ijscr.2021.106224.
[9] Chen F, Muranishi Y, Minakata K, et al.Complete resection of a giant mediastinal leiomyosarcoma[J].Ann Thorac Surg, 2015, 99(3):e69-e71.DOI:10.1016/j.athoracsur.2014.12.024.
[10] Acharya M, Jamali A, Rao J.Giant costal chondrosarcoma in a patient with hereditary multiple exostoses[J].Ann Thorac Surg, 2014, 98(5):1848.DOI:10.1016/j.athoracsur.2014.06.081.
[11] Galluzzo A, Fatica F, Caternicchia F, et al.3D CT scan for perioperative identification of anatomical variations of lungs[J].Future Oncol, 2016, 12(23s):27-30.DOI:10.2217/fon-2016-0344.
[12] Chen-Yoshikawa TF, Date H.Update on three-dimensional image reconstruction for preoperative simulation in thoracic surgery[J].J Thorac Dis, 2016, 8(Suppl 3):S295-S301.DOI:10.3978/j.issn.2072-1439.2016.02.39.
[13] Feng Z, Li M, Liu F, et al.Analysis of giant thoracic neoplasms:Correlations between imaging, pathology and surgical management[J].Thorac Cancer, 2017, 8(5):402-409.DOI:10.1111/1759-7714.12448.
[14] Huang ZG, Sun HL, Wang CL, et al.CT-guided transthoracic needle biopsy of pulmonary lesions:comparison between the cutting needle and aspiration needle[J].Br J Radiol, 2021, 94(1118):20190930.DOI:10.1259/bjr.20190930.
[15] Ocak S, Duplaquet F, Jamart J, et al.Diagnostic accuracy and safety of ct-guided percutaneous transthoracic needle biopsies:14-gauge versus 22-gauge needles[J].J Vasc Interv Radiol, 2016, 27(5):674-681.DOI:10.1016/j.jvir.2016.01.134.
[16] Yohe S, Thyagarajan B.Review of Clinical Next-Generation Sequencing[J].Arch Pathol Lab Med, 2017, 141(11):1544-1557.DOI:10.5858/arpa.2016-0501-RA.
[17] Lu Y, Dai W, Zong Z, et al.Bronchial blocker versus left double-lumen endotracheal tube for one-lung ventilation in right video-assisted thoracoscopic surgery[J].J Cardiothorac Vasc Anesth, 2018, 32(1):297-301.DOI:10.1053/j.jvca.2017.07.026.
[18] Li Y, Wang J.Experience of video-assisted thoracoscopic resection for posterior mediastinal neurogenic tumours:a retrospective analysis of 58 patients[J].ANZ J Surg, 2013, 83(9):664-668.DOI:10.1111/j.1445-2197.2012.06174.x.
[19] Yang H, Chen R, Chen J, et al.ECMO-assisted resection of left main bronchial malignant tumor and left pneumonectomy with comprehensive nursing support:a case report[J].J Cardiothorac Surg, 2020, 15(1):300.DOI:10.1186/s13019-020-01348-z.
[20] Ansell SM.Hodgkin Lymphoma:Diagnosis and Treatment[J].Mayo Clin Proc, 2015, 90(11):1574-1583.DOI:10.1016/j.mayocp.2015.07.005.
[21] Mastrangelo S, Attinà G, Ruggiero A.131-I-metaiodobenzylguanidine and chemotherapy for advanced neuroblastoma[J].Expert Rev Clin Pharmacol, 2021, 14(11):1325-1327.DOI:10.1080/17512433.2021.1960821.
[22] Chen X, Kong H, Luo L, et al.High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma[J].BMC Cancer, 2022, 22(1):9.DOI:10.1186/s12885-021-09028-4.
[23] Ohaegbulam KC, Assal A, Lazar-Molnar E, et al.Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway[J].Trends Mol Med, 2015, 21(1):24-33.DOI:10.1016/j.molmed.2014.10.009.
[24] Martinez M, Moon EK.CAR T Cells for Solid Tumors:New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment[J].Front Immunol, 2019, 10:128.DOI:10.3389/fimmu.2019.00128.
[25] Sahin U, Tureci O.Personalized vaccines for cancer immunotherapy[J].Science, 2018, 359(6382):1355-1360.DOI:10.1126/science.aar7112.